Neonatal Drug Therapy: The First Frontier of Therapeutics for Children
Clinical Pharmacology and Therapeutics , Volume 98 - Issue 3 p. 288- 297
Knowledge about the safe and effective use of medicines in neonates has increased substantially but has resulted in few label changes. Drugs developed for use in adults are reshaped and tailored to specific neonatal indications. However, the use of drugs in neonates should not only mirror adult pharmacotherapy, but should be driven by their own specific needs. Therefore, building collaborative networks may assist to develop a newborn- driven research agenda addressing their clinical needs and diseases.
|Clinical Pharmacology and Therapeutics|
|Organisation||Department of Intensive Care|
Allegaert, K.M, & Anker, J.V.D. (2015). Neonatal Drug Therapy: The First Frontier of Therapeutics for Children. Clinical Pharmacology and Therapeutics (Vol. 98, pp. 288–297). doi:10.1002/cpt.166